{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:16:14Z","timestamp":1791645374560,"version":"4.3.4"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1097\/01.jcp.0000170686.27476.ab","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T10:54:33Z","timestamp":1121165673000},"page":"293-300","source":"Crossref","is-referenced-by-count":7,"title":["Risperidone"],"prefix":"10.1097","volume":"25","author":[{"given":"Frank-Gerald","family":"Pajonk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Rettig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Degner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckart","family":"R\u00fcther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0920-9964(01)00254-7","article-title":"One year outcome in first episode psychosis: influence of DUP and other predictors.","volume":"54","author":"Malla","year":"2002","journal-title":"Schizophr Res"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archpsyc.1997.01830170079011","article-title":"Relapse and rehospitalization during maintenance treatment of schizophrenia The effects of dose reduction and family treatment.","volume":"54","author":"Schooler","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"R3-2-20210128","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2174\/1381612043384042","article-title":"Drug therapy in schizophrenia.","volume":"10","author":"Ananth","year":"2004","journal-title":"Curr Pharm Des"},{"key":"R4-2-20210128","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1176\/ps.50.12.1553","article-title":"Emergency psychiatry: contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms.","volume":"50","author":"Binder","year":"1999","journal-title":"Psychiatr Serv"},{"key":"R6-2-20210128","first-page":"329","article-title":"Current assessment of new\/atypical neuroleptic agents.","volume":"71","author":"Moller","year":"2000","journal-title":"Nervenarzt"},{"key":"R8-2-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0163-8343(00)00055-4","article-title":"Second-generation antipsychotics in the emergency care setting. A prospective naturalistic study.","volume":"22","author":"Raja","year":"2000","journal-title":"Gen Hosp Psychiatry"},{"key":"R9-2-20210128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00004714-199602000-00007","article-title":"Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.","volume":"16","author":"Blin","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0447.1993.tb03480.x","article-title":"Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations.","volume":"88","author":"Hoyberg","year":"1993","journal-title":"Acta Psychiatr Scand"},{"key":"R11-2-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0447.1995.tb09781.x","article-title":"Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.","volume":"91","author":"Huttunen","year":"1995","journal-title":"Acta Psychiatr Scand"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1176\/ajp.151.6.825","article-title":"Risperidone in the treatment of schizophrenia.","volume":"151","author":"Marder","year":"1994","journal-title":"Am J Psychiatry"},{"key":"R13-2-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0278-5846(03)00164-7","article-title":"Risperidone in acute and long-term therapy of schizophrenia-a clinical profile.","volume":"28","author":"Pajonk","year":"2004","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"R14-2-20210128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2007-1014355","article-title":"Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.","volume":"26","author":"Ceskova","year":"1993","journal-title":"Pharmacopsychiatry"},{"key":"R15-2-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4088\/JCP.v62n0303","article-title":"Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.","volume":"62","author":"Currier","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R16-2-20210128","first-page":"461","article-title":"Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility.","volume":"25","author":"Beck","year":"1997","journal-title":"J Am Acad Psychiatry Law"},{"key":"R17-2-20210128","first-page":"173","article-title":"Aggression and schizophrenia: efficacy of risperidone.","volume":"25","author":"Buckley","year":"1997","journal-title":"J Am Acad Psychiatry Law"},{"key":"R18-2-20210128","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/070674370004500907","article-title":"Impact of risperidone on seclusion and restraint at a state psychiatric hospital.","volume":"45","author":"Chengappa","year":"2000","journal-title":"Can J Psychiatry"},{"key":"R19-2-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004714-199508000-00002","article-title":"Effect of risperidone on hostility in schizophrenia.","volume":"15","author":"Czobor","year":"1995","journal-title":"J Clin Psychopharmacol"},{"issue":"suppl 3","key":"R20-2-20210128","first-page":"4","article-title":"The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.","volume":"61","author":"Keck","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R21-2-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.jcp.0000126660.50788.ef","article-title":"Risperidone in the treatment of acute schizophrenia.","volume":"24","author":"Raedler","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"suppl 14","key":"R22-2-20210128","first-page":"21","article-title":"Atypical antipsychotic medications in the psychiatric emergency service.","volume":"61","author":"Currier","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"suppl 2","key":"R23-2-20210128","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0924-977X(96)00013-2","article-title":"Managing the first episode of schizophrenia: the role of new therapies.","volume":"6","author":"McCreadie","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"R24-2-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJMoa002028","article-title":"A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.","volume":"346","author":"Csernansky","year":"2002","journal-title":"N Engl J Med"},{"key":"R25-2-20210128","first-page":"14","article-title":"Factors which can make patients difficult to treat.","volume":"10-","author":"Kane","year":"1996","journal-title":"Br J Psychiatry Suppl"},{"key":"R26-2-20210128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1176\/appi.ajp.158.2.266","article-title":"Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics.","volume":"158","author":"Rabinowitz","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R27-2-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-979520","article-title":"Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The \"Phase IV Research\" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP).","volume":"30","author":"Linden","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"R28-2-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2003-39063","article-title":"Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients-an interim analysis.","volume":"71","author":"Pajonk","year":"2003","journal-title":"Fortschr Neurol Psychiatr"},{"key":"R30-2-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-002-1051-0","article-title":"Life is not so easy. Individualization in clinical psychopharmacology.","volume":"162","author":"Gerlach","year":"2002","journal-title":"Psychopharmacology (Berlin)"},{"key":"R31-2-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.jcp.0000106224.36344.11","article-title":"Psychotropic prescribing for acute inpatient admissions in patients with severe psychosis.","volume":"24","author":"Lambert","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R32-2-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00213-002-1055-9","article-title":"Comparing the efficacy of atypical antipsychotics in open uncontrolled versus double-blind controlled trials in schizophrenia.","volume":"162","author":"Pajonk","year":"2002","journal-title":"Psychopharmacology (Berlin)"},{"key":"R33-2-20210128","first-page":"165","article-title":"Long-term treatment of schizophrenia with risperidone: an international multicenter, open label trial.","volume":"14","author":"Karavias","year":"1998","journal-title":"New Trends Exp Clin Psychiatry"},{"issue":"suppl 1","key":"R34-2-20210128","first-page":"19","article-title":"Risperidone in first-episode schizophrenia: improvement in symptoms and pre-existing extrapyramidal signs.","volume":"2","author":"Kopala","year":"1998","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R35-2-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(99)00075-X","article-title":"Amisulpiride versus Risperidone in the treatment of acute exacerbations of schizophrenia.","volume":"88","author":"Peuskens","year":"1999","journal-title":"Psychiatry Res"},{"key":"R36-2-20210128","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.jcp.0000085406.08426.a8","article-title":"Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation.","volume":"23","author":"Baker","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R37-2-20210128","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1023\/B:QURE.0000021687.18783.d6","article-title":"Perceived quality of life in schizophrenia: relationships to sleep quality.","volume":"13","author":"Ritsner","year":"2004","journal-title":"Qual Life Res"},{"key":"R38-2-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0924-977X(01)00097-9","article-title":"Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials.","volume":"11","author":"Aleman","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"R40-2-20210128","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4088\/JCP.v63n1006","article-title":"Risperidone, 2 mg\/day vs. 4 mg\/day, in first-episode, acutely psychotic patients: treatment efficacy and effects on fine motor functioning.","volume":"63","author":"Merlo","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R41-2-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0033-3182(86)72735-7","article-title":"Alternative approaches in the treatment of psychotic agitation.","volume":"27","author":"Campbell","year":"1986","journal-title":"Psychosomatics"},{"issue":"suppl","key":"R42-2-20210128","first-page":"5","article-title":"Rapid tranquilization: antipsychotics or benzodiazepines?","volume":"49","author":"Dubin","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"R43-2-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004850-199705000-00009","article-title":"Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting.","volume":"12","author":"Foster","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"R44-2-20210128","first-page":"114","article-title":"Practice guideline for the treatment of patients with schizophrenia. Second edition.","volume":"1-","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R45-2-20210128","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1039-8562.2003.00535.x","article-title":"Summary Australian and New Zealand clinical practice guideline for the treatment of schizophrenia.","volume":"11","author":"McGorry","year":"2003","journal-title":"Australas Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.jcp.0000170686.27476.ab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:47:58Z","timestamp":1620938878000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200508000-00002"}},"subtitle":["An Open-Label, Observational Study of the Efficacy, Tolerability, and Prescribing Behavior in Acutely Exacerbated Patients With Schizophrenia"],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000170686.27476.ab","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}